223 related articles for article (PubMed ID: 35443517)
1. Utility of Neutrophil-Lymphocyte Ratio (NLR) as an Indicator of Disease Severity and Prognostic Marker among Patients with Covid-19 Infection in a Tertiary Care Centre in Bangalore - A Retrospective Study.
PrakashRao VV
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443517
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Impact of Inflammatory Markers and CT Severity Score on Disease Severity of COVID-19 Patients Admitted to ICU at a Tertiary Hospital.
Kurri N; Tyagi B; Singhal E; Gupta N; Agarwal AK; Gupta V; Rai G; Bindra MS
J Assoc Physicians India; 2021 Jun; 69(6):11-12. PubMed ID: 34472783
[TBL] [Abstract][Full Text] [Related]
3. Complete Blood-count-based Inflammatory Score (CBCS) of COVID-19 Patients at Tertiary Care Center.
Kumar Gothwal S; Singh VB; Shrivastava M; Banseria R; Goyal K; Singh S; Ali H; Saad Alharbi K; Singh Y; Gupta G
Altern Ther Health Med; 2021 Jun; 27(S1):18-24. PubMed ID: 33609349
[TBL] [Abstract][Full Text] [Related]
4. The use of neutrophil-to-lymphocyte ratio (NLR) as a marker for COVID-19 infection in Saudi Arabia: A case-control retrospective multicenter study.
Sayed AA; Allam AA; Sayed AI; Alraey MA; Joseph MV
Saudi Med J; 2021 Apr; 42(4):370-376. PubMed ID: 33795491
[TBL] [Abstract][Full Text] [Related]
5. Correlation of Computed Tomography (CT) Severity Score With Laboratory and Clinical Parameters and Outcomes in Coronavirus Disease 2019 (COVID-19).
Pamulapati BK; Nanjundappa RK; Chandrabhatla BS; Roohi SU; Palepu S
Cureus; 2024 Jan; 16(1):e52324. PubMed ID: 38361692
[TBL] [Abstract][Full Text] [Related]
6. The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study.
Fonseca JA; Gameiro J; Duarte I; Jorge S; Lopes JA
Nefrologia (Engl Ed); 2021; 41(3):321-328. PubMed ID: 33309337
[TBL] [Abstract][Full Text] [Related]
7. Limited value of neutrophil-to-lymphocyte ratio and serum creatinine as point-of-care biomarkers of disease severity and infection mortality in patients hospitalized with COVID-19.
Tufa A; Gebremariam TH; Manyazewal T; Asrat Y; Getinet T; Hundie TG; Webb DL; Hellström PM; Genet S
PLoS One; 2022; 17(10):e0275391. PubMed ID: 36201435
[TBL] [Abstract][Full Text] [Related]
8. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, and eosinophils correlation with high-resolution computer tomography severity score in COVID-19 patients.
Man MA; Rajnoveanu RM; Motoc NS; Bondor CI; Chis AF; Lesan A; Puiu R; Lucaciu SR; Dantes E; Gergely-Domokos B; Fira-Mladinescu O
PLoS One; 2021; 16(6):e0252599. PubMed ID: 34181675
[TBL] [Abstract][Full Text] [Related]
10. The Diagnostic and Predictive Roles of Neutrophil-Lymphocyte Ratio for Severity of Disease in COVID-19 Patients.
Islamoglu MS; Borku-Uysal B; Yavuzer S; Ikitimur H; Seyhan S; Koc S; Cengiz M
Clin Lab; 2021 Dec; 67(12):. PubMed ID: 34910428
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients.
Abdelhady SA; Rageh F; Ahmed SS; Al-Touny SA; Riad E; Elhoseeny MM; Khalifa AA; Salim A; Farghly MI; Elgamal R
Egypt J Immunol; 2022 Apr; 29(2):57-67. PubMed ID: 35436055
[TBL] [Abstract][Full Text] [Related]
12. Comparison of hemoglobin level and neutrophil to lymphocyte ratio as prognostic markers in patients with COVID-19.
Fouad SH; Allam MF; Taha SI; Okba AA; Hosny A; Moneer M; Roman SW
J Int Med Res; 2021 Jul; 49(7):3000605211030124. PubMed ID: 34250826
[TBL] [Abstract][Full Text] [Related]
13. Role of neutrophil-to-lymphocyte, lymphocyte-to-monocyte and platelet-to-lymphocyte ratios as predictors of disease severity in COVID-19 patients.
Kalabin A; Mani VRK; Valdivieso SC; Donaldson B
Infez Med; 2021 Mar; 29(1):46-53. PubMed ID: 33664172
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of neutrophil-to-lymphocyte ratio, lactate dehydrogenase, D-dimer, and computed tomography score in patients with coronavirus disease 2019.
Cai YQ; Zhang XB; Zeng HQ; Wei XJ; Hu L; Zhang ZY; Ming Q; Peng QP; Chen LD
Aging (Albany NY); 2021 Sep; 13(17):20896-20905. PubMed ID: 34495869
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19.
Jimeno S; Ventura PS; Castellano JM; García-Adasme SI; Miranda M; Touza P; Lllana I; López-Escobar A
Eur J Clin Invest; 2021 Jan; 51(1):e13404. PubMed ID: 32918295
[TBL] [Abstract][Full Text] [Related]
16. Dynamic Profile of Prognostic Hematologic Indicators in Patient Under Intensive Care for COVID-19 Disease: A One-Year Study at a Tertiary Care Centre in South India.
Balasubramanian J; Suman FR; Stephen IR; Shanmugam SG; Mani R; Mathan B; P L
Cureus; 2021 Nov; 13(11):e19585. PubMed ID: 34926056
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the neutrophil-to-lymphocyte ratio and C-reactive-protein-to-prealbumin ratio in hospitalized older patients with coronavirus disease 2019.
Pan K; Jin Y; Du W; Wang M; Zhang Y; Liu S; Zhang Y
Medicine (Baltimore); 2024 Apr; 103(16):e37809. PubMed ID: 38640293
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of individual and combined NLR, LMR and CLR ratio for prognosis disease severity and outcomes in patients with COVID-19.
Ben Jemaa A; Salhi N; Ben Othmen M; Ben Ali H; Guissouma J; Ghadhoune H; Oueslati R; Dhaouadi H
Int Immunopharmacol; 2022 Aug; 109():108781. PubMed ID: 35461157
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil/lymphocyte ratio-A marker of COVID-19 pneumonia severity.
Imran MM; Ahmad U; Usman U; Ali M; Shaukat A; Gul N
Int J Clin Pract; 2021 Apr; 75(4):e13698. PubMed ID: 32892477
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil to Lymphocyte Ratio (NLR) and Derived NLR Combination: A Cost-effective Predictor of Moderate to Severe COVID-19 Progression.
Ardestani SK; Salehi MR; Attaran B; Hashemi SM; Sadeghi S; Ghaffarpour S; Tuserkani F; Ghazanfari T
Iran J Allergy Asthma Immunol; 2022 Jun; 21(3):241-253. PubMed ID: 35822675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
